Aitia’s CEO Wants You to Use AI to Do More than Designing Drugs Against Known Validated Targets
AI in the pharma R&D world isn’t just about designing better drugs against known drug targets, according to Aitia’s CEO, Colin Hill. Hear what Colin had to say on how powerful AI can be in understanding novel human causal biology, creating novel drugs, and enhancing patient selection in clinical trials. Full article on DPHARM, here. […]
Colin Hill to Speak at Convergence Forum 2024
We’re thrilled to announce our participation at the Convergence Forum on May 9-10, 2024. Colin Hill will be a featured panelist in an engaging session titled: “Where Will AI Make the Biggest Impact This Year..and in the Future? What Should Your Organization Be Doing?” alongside Anna Huyghues-Despointes, Chief Corporate Development and Strategy Officer at Owkin […]
Colin Hill to Speak at Align Summit 2024
Join us at this year’s Align Summit, where the spotlight shines on artificial intelligence and machine learning in drug discovery and development. Our CEO, Colin Hill, will discuss Aitia’s strategic initiatives and recent collaborations in the realm of AI-enabled drug discovery. Learn more about the event and our participation here.
Colin Hill to Speak on AI’s Impact at MIT Imagination in Action Summit
Delighted to share that Colin Hill will be taking the stage as a featured speaker at the upcoming Imagination in Action Summit at MIT #MITforge2024 on April 18th! Anticipate invaluable insights into AI’s transformative impact on Life Sciences & Health. Get ready for groundbreaking perspectives at the forefront of innovation. More information about this event […]
Colin Hill to Speak at Yale Healthcare Conference
Delighted to share that Colin Hill will be taking the stage as a featured panelist at the upcoming Yale Healthcare Conference, on April 12th, 2024. Colin’s panel discussion titled “Not-So-Secret Weapon to Better Care: Precision Medicine for All” will explore the transformative role of AI in reshaping the landscape of drug discovery and development towards […]
Join Aitia at AACR Annual Meeting
Join us at the AACR Annual Meeting in San Diego on April 5 – 10, 2024. This meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to […]
Digital Twins: When AI drives progress for the pharmaceutical industry
In its inaugural edition, Servier digital magazine, Insights, features Aitia’s Gemini Digital Twins in its “Science Calling” section. The conversion of causal AI and Gemini Digital Twins with industrial expertise holds the potential to significantly expedite R&D phases and streamline the identification of new targets. In May 2023, Aitia and Servier inked a multi-year agreement […]
How Digital Twins are Transforming Medicine
What if you could test a drug candidate on people before clinical trials? What if, instead of mice, a human computer model could be the first “lab rat” to determine the efficacy of a molecule, or to provide insight into a potential drug target? Hear from our CEO, Colin Hill, as he unveils the transformative […]
Meet Aitia at the AD/PD Summit
Join us at the AD/PD Summit in Lisbon, Portugal on March 5 – 9, 2024. This conference is exclusively focused on advancing innovative strategies in therapy, prevention, clinical trials and diagnostic markers, in order to focus on driving successful collaborations among academia and industry, and finally leading to the development of innovative therapies. Make sure […]
R&D Leadership Summit to Accelerate R&D Productivity Enhancement Opportunities
The R&D Leadership Summit convenes industry experts and leaders from the biopharmaceutical field to delve into pivotal topics shaping the trajectory of research and development. On March 4th, our CEO, Colin Hill, will be part of a panel to discuss the transformative potential of AI and its profound implications in drug discovery. The discussion will center […]